Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Annals of Transplantation|November 17, 2018
Results of Adult Living Donor Liver Transplantation with Sixth-Decade Donors: A Propensity Score Matching Study in a High-Volume InstitutionSeok-Hwan Kim, Gil-Chun Park, Shin Hwang, et al.
Transplantation Proceedings|June 24, 2020
Life-Threatening Portal Flow Steal Reappearing Under Increased Intrahepatic Vascular Resistance After Living Donor Liver TransplantationJae-Hyun Kwon, Young-In Yoon, Deok-Bog Moon, et al.
Annals of Surgical Treatment and Research|February 14, 2020
Is renal replacement therapy necessary in deceased donor liver transplantation candidates with hepatorenal syndrome?: a 2-year experience at a high-volume centerGil-Chun Park, Shin Hwang, Dong-Hwan Jung, et al.
Journal of Korean Medical Science|October 5, 2019
Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B ProphylaxisShin Hwang, Gi Won Song, Young Kyu Chung, et al.
Korean Journal of Transplantation|June 30, 2022
Cross-sectional analysis of immunosuppressive regimens focused on everolimus after liver transplantation in a Korean high-volume transplantation centerSang-Hyun Kang, Shin Hwang, Tae-Yong Ha, et al.
Korean Journal of Transplantation|June 30, 2022
Changes in the indications for living donor liver transplantation: single-institution experience of 3,145 cases over 10 yearsSang-Hyun Kang, Shin Hwang, Chul-Soo Ahn, et al.
Korean Journal of Transplantation|June 30, 2022
Long-term patency and complications of ringed polytetrafluoroethylene grafts used for middle hepatic vein reconstruction in living-donor liver transplantationI-Ji Jung, Shin Hwang, Tae-Yong Ha, et al.
Journal of Korean Medical Science|March 21, 2020
Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver TransplantationGil Chun Park, Shin Hwang, Chul Soo Ahn, et al.
Annals of Transplantation|December 18, 2019
Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver TransplantationGil-Chun Park, Shin Hwang, Tae-Yong Ha, et al.
Journal of Cellular and Molecular Medicine|July 22, 2024
SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS-mediated cell deathJooyoung Lee, Jiye Kim, Ryunjin Lee, et al.
Pageof 13